Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/23894
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12708]
Metadata
Show full item record
A WORLDWIDE MAP OF PLASMODIUM FALCIPARUM K13-PROPELLER POLYMORPHISMS
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ. Brasil.
Abstract
BACKGROUND
Recent gains in reducing the global burden of malaria are threatened by the emergence of
Plasmodium falciparum resistance to artemisinins. The discovery that mutations in portions
of a P. falciparum gene encoding kelch (K13)–propeller domains are the major determinant
of resistance has provided opportunities for monitoring such resistance on a global scale.
METHODS
We analyzed the K13-propeller sequence polymorphism in 14,037 samples collected in
59 countries in which malaria is endemic. Most of the samples (84.5%) were obtained
from patients who were treated at sentinel sites used for nationwide surveillance of
antimalarial resistance. We evaluated the emergence and dissemination of mutations
by haplotyping neighboring loci.
RESULTS
We identified 108 nonsynonymous K13 mutations, which showed marked geographic
disparity in their frequency and distribution. In Asia, 36.5% of the K13 mutations were
distributed within two areas — one in Cambodia, Vietnam, and Laos and the other in
western Thailand, Myanmar, and China — with no overlap. In Africa, we observed a
broad array of rare nonsynonymous mutations that were not associated with delayed
parasite clearance. The gene-edited Dd2 transgenic line with the A578S mutation, which
expresses the most frequently observed African allele, was found to be susceptible to
artemisinin in vitro on a ring-stage survival assay.
CONCLUSIONS
No evidence of artemisinin resistance was found outside Southeast Asia and China,
where resistance-associated K13 mutations were confined. The common African A578S
allele was not associated with clinical or in vitro resistance to artemisinin, and many
African mutations appear to be neutral. (Funded by Institut Pasteur Paris and others.
Share